"The price of greatness is responsibility." Sir Winston Churchill


Search the IBPA



IBPA Issues
About IBPA
IBPA Constitution
FAQ-s
IBPA Events
Individual Membership
Institutional Membership
IBPA Forums / Groups
Cooperation with IBPA
Links

Publications
IBPA Careers Newsletter
Past Issues
Industry Publications
Promote Yourself within the Industry
Submit Your Article

Career Center: Employers
Job Posting
Free Resume Database
Volunteers Database

Career Center: Job Seekers
Now Hiring
Submit Resume
Career Training
Nurses Careers in Biopharm
Scholarship Programs
Internship Programs
Resume Editing & Interview Coaching
Volunteer for the Industry
Download IBPA Career Info Brochure

Industry Directories and Listings
Pharmaceutical Companies
Contract Research Organizations
Professional Associations
Recruiters and Staffing Agencies
Clinical Research Centers
Consulting Companies
Education & Training Institutions
Jobs and Resume Searching Directories
Research and Development Companies
List Your Company

Investor's Center
Offers
Calls

Contact IBPA
US Chapter
Canadian Chapter
European Chapter
Asian Chapter

Start Your Career in Biotech with IBPA Scholarship Programs
Untitled Document



Subscribe to our "Careers in the Biopharmaceutical Industry" newsletter:

Name*:

Email*:

City:

Country:

Phone:

To unsubscribe, click here

 

 

Multicenter trial

From Wikipedia, the free encyclopedia

 

Multicenter research trial. A clinical trial that's conducted at more than one medical center or clinic. Most large clinical trials are conducted at several clinical research centers. The benefits of multicenter trials include a larger number of participants, different geographic locations, various ethnic groups and the ability to compare results among centers, all of which increase the generalizability of the study.

Contents

[hide]

[edit]

 

Competitive Enrollment

Enrolment should be competitive. If the subject recruitment rate is lower than expected at one centre and higher than expected at another, planned allocation numbers should be transferred from the centre with low subject recruitment to a centre with high recruitment where subject inclusion is expected to be completed earlier than planned. This will be done to help ensure that subject enrolment is completed as planned.

[edit]

 

Set up costs

The low set up costs should be negotiated in order to enable to sign agreements with larger number of sites.

[edit]

 

Expected subject recruitment rate

Expected subject recruitment rate should be evaluated. Subject enrolment ends when the planned number of subjects is reached. The recruitment rates estimate should be based on retrospective data provided by the investigator(s) from previous studies, i.e., on the number of subjects who would have satisfied the proposed inclusion/exclusion criteria in the past.

The investigator(s) should make every effort to ensure that the planned accrual rate is maintained, that CRF’s are completed promptly and completely, and that data quality is maintained at all times. The investigator(s) should discuss with the monitor any anticipated problems with recruitment or delays in study completion.

Number of sites for the study depends on estimated recruitment rates.   

Although, without outside assistance, the typical site may recruit as few as one-fifth of the patients it promised to deliver originally. Some may recruit none, taking their setup money and contributing nothing more, or recruit only one patient so that there is no offsetting control.


External links




Learn More About the Biopharmaceutical Industry and Clinical Research:


Category:


Powered by Wikipedia, the free encyclopedia. Articles were developed by IBPA volunteers.

A

B

C

D

E

F

G

I

K

L

M

N

P

Q

R

S

T


©2004 International Biopharmaceutical Association Inc., all rights reserved
Privacy Policy - Terms of Use

Google